-- BTIG starts on Hims Hers Health Inc (NYSE:HIMS) with a "buy" rating and a price target of $35 given the company’s disruptive direct-to-consumer healthcare model....
-- Jasper Therapeutics, a pharmaceutical company, experienced a significant drop in its stock value, with shares falling by up to 52% in premarket trading. This...
-- Nvidia (NASDAQ:NVDA), Microsoft (NASDAQ:MSFT), and OpenAI are the key AI beneficiaries, UBS analysts said, citing results of its latest enterprise AI survey. The...
-- Jefferies analysts recently upgraded their rating on GE HealthCare (NASDAQ:GEHC) Technologies Inc. to "buy" from "hold," reflecting a more optimistic outlook for...
This article summarizes the most significant insider buying and selling activities reported on Tuesday for US stocks. Top Buys: MDB Capital Holdings, LLC (NASDAQ:MDBH): Anthony...
-- Shares of Accolade (NASDAQ:ACCD) surged 100% following the announcement that Transcarent will acquire the health advocacy and primary care company for $7.03 per...
-- Shares in US wind energy names, including GE Vernova (NYSE:GEV), fell in premarket trading on Wednesday after comments from President-elect Donald Trump indicating...
-- Shares of Revance Therapeutics (NASDAQ:RVNC) climbed 3% in pre-open trading Wednesday following news it will engage in discussions with Teoxane about a potential...
-- Morgan Stanley labelled Sony (NYSE:SONY) its top pick in consumer electronics and Japan semiconductors given its sustained growth prospects for its games &...
-- OpenAI Chief Executive Sam Altman has refuted the allegations of sexually abusing his sister, Ann Altman, during their childhood, Reuters reported on Wednesday....